By Derek Pendlebury
As cell and gene therapy (CGT) manufacturing processes evolve, some learnings can be transferred from the bioprocessing industry. CGTs have many of the same manufacturing needs as biopharmaceuticals. The single use technologies used in current biopharmaceutical clinical trials and commercial production are expected to play a large role in the future development and production of CGT. Discover learnings about single use connection technology that apply to CGT manufacturing here.